Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label attachment file name title previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1140560

	registered interest
	date	19/07/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Kawasaki Disease: Research
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent comparative assessment he has made of the UK level of research funding into Kawasaki disease with that of other EU member states.
	tabling member constituency	Cardiff West
	tabling member printed	Kevin Brennan
	uin	279384
	answer	answer is ministerial correction date of answer 25/07/2019 answer text <p>The Department has not made a recent comparative assessment of the United Kingdom level of research funding into Kawasaki disease with that of other European Union member states.</p><p> </p><p>The EU has recently agreed to fund a Kawasaki disease study led from Great Ormond Street Hospital/University College London. The trial, which aims to recruit 262 children from 40 centres across Europe, will look at the effectiveness of using of steroids in addition to the standard treatment for Kawasaki syndrome, intravenous immunoglobulins. The award is for over €5 million in funding for the trial to be run through a new European consortium, connect4children.</p><p> </p><p>The National Institute for Health Research (NIHR) Imperial Biomedical Research Centre was funded between 2013-18 to carry out a project on the ‘Genetic determinants of Kawasaki disease for susceptibility and outcome’ with NIHR funding of £77,000.</p><p><strong> </strong></p><p><strong> </strong></p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 25/07/2019 14:19:10 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 131092 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1400 label Biography information for Kevin Brennan

1104733

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	General Practitioners: Blackpool
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what the average waiting time for patients to see their GP in the Blackpool NHS Clinical Commissioning Group has been for non-emergency appointments (a) between June and September 2018, (b) between October and December 2018, (c) in January 2019 and (d) in February 2019.
	tabling member constituency	Blackpool South
	tabling member printed	Gordon Marsden
	uin	236307
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>A table showing the time between booking an appointment with a general practice and having the appointment (in days) for Blackpool Clinical Commissioning Group (CCG) for June – September 2018 (inclusive), October – December 2018 (inclusive) and January 2018 only is attached. There are seasonal variations in the general practitioner (GP) appointment data therefore a 12-month average (February 2018-January 2019) is also presented. NHS Digital’s ‘Appointments in General Practice’ data is published monthly with a two-month time lag. Data covering February 2019 will be published on the NHS Digital website on 4 April 2019 and will include a regional breakdown by sub-region, sustainability and transformation partnership and CCG.</p><p>It is not possible to differentiate the time between booking an appointment and having the appointment by healthcare professional, therefore the data includes appointments with GPs and other practice staff. The appointments data does not differentiate between emergency and routine appointments in general practice and the ‘time from booking to appointment’ does not take into consideration that many patients will be appropriately booking ahead as part of the continuity of care they receive for long-term conditions.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:52:49 answering member 4008 label Biography information for Dame Caroline Dinenage attachment 1 file name PQ236307 wait times blackpool table.docx title PQ236307 attached information previous answer version 110766 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	465 label Biography information for Gordon Marsden

1104798

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans the Government and NHS England have to ensure that CCGs use the funding allocated nationally to prescribe Flash Glucose Monitoring from 1 April 2019 using central NHS criteria.
	tabling member constituency	Wakefield
	tabling member printed	Mary Creagh
	uin	236412
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf</a></p><p> </p><p>CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p><p> </p><p>NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.</p><p> </p><p>Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 236413 236414 question first answered 29/03/2019 14:47:45 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110760 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1579 label Biography information for Mary Creagh

1104799

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what steps NHS England is taking to encourage CCGs which do not prescribe Flash Glucose Monitoring technology to do so as soon as possible when new guidance comes into effect from 1 April 2019.
	tabling member constituency	Wakefield
	tabling member printed	Mary Creagh
	uin	236413
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf</a></p><p> </p><p>CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p><p> </p><p>NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.</p><p> </p><p>Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 236412 236414 question first answered 29/03/2019 14:47:45 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110770 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1579 label Biography information for Mary Creagh

1104800

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Diabetes: Medical Equipment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, which CCGs do not currently prescribe Flash Glucose Monitoring kits.
	tabling member constituency	Wakefield
	tabling member printed	Mary Creagh
	uin	236414
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>In November 2018, NHS England announced action to end the current variation in accessing flash glucose monitors. From April 2019 there will be a more consistent national approach to making these devices available. Clinical commissioning groups (CCGs) will be reimbursed to cover the costs of flash glucose monitoring sensors for those type 1 diabetes patients who are most likely to benefit from their use. NHS England has published detailed criteria and supporting guidance at the following link:</p><p> </p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2019/03/flash-glucose-monitoring-national-arrangements-funding.pdf</a></p><p> </p><p>CCGs will be reimbursed for the cost of flash glucose monitoring sensors for those who meet these criteria, which could amount to up to 20% of their type 1 diabetes populations. CCGs can also locally choose to fund flash glucose monitoring for other patients with diabetes. The guidance advises that as part of their annual review process, patients with diabetes should be assessed for suitability for flash glucose monitoring. This process can also form part of a review for a different purpose, if that occurs earlier. This will promote a systematic approach to increasing take up.</p><p> </p><p>NHS England has engaged with NHS Clinical Commissioners, the membership organisation for CCGs, regarding the planned arrangements so that they can advise their members as appropriate. An FAQ for patients and commissioners is also being prepared and will be published, to aid the implementation. NHS England is also in conversations with the Academic Health Science Network to identify the capacity and scope for them to aid in rolling out flash glucose monitoring.</p><p> </p><p>Due to the limitations of the data collected by the NHS Business Services Authority, it is not possible to conclusively state which CCGs do or do not currently prescribe flash glucose monitors.</p> answering member constituency Gosport answering member printed Caroline Dinenage grouped question UIN 236412 236413 question first answered 29/03/2019 14:47:45 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110772 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	1579 label Biography information for Mary Creagh

1104903

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the effectiveness of support for people suffering from myalgic encephalomyelitis in (a) South Shields and (b) the North East.
	tabling member constituency	South Shields
	tabling member printed	Mrs Emma Lewell-Buck
	uin	236446
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>No assessment has been made. Services for people with chronic fatigue syndrome/myalgic encephalomyelitis are commissioned by local clinical commissioning groups to meet local need, including addressing any shortfalls in provision, taking into account best practice guidance, such as that produced by the National Institute for Health and Care Excellence.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:41:18 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110762 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4277 label Biography information for Mrs Emma Lewell-Buck

1104905

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Cervical Cancer: Screening
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what recent steps his Department is taking to improve access to cervical cancer screenings.
	tabling member constituency	Coventry South
	tabling member printed	Mr Jim Cunningham
	uin	236300
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>NHS England is investing in initiatives to help ensure equality of access to screening. These include locally-targeted interventions such as text and general practitioners (GP) reminders.</p><p> </p><p>As part of the delivery of the GP Five Year Forward View, the NHS has invested more than £258 million this year to improve access to general practice, including improved access to all routine appointments (including screening) at weekends and/or evenings.</p><p> </p><p>The UK National Screening Committee recently reviewed the evidence for self-sampling as part of the programme modifications to the NHS Cervical Screening programme, to support non-attendance and access. The Committee will submit its recommendations shortly.</p><p> </p><p>In addition, Professor Sir Mike Richards, as part of his review which was commissioned by NHS England to review screening programmes in England, will further consider ways to increase uptake of and access to cervical screening.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:49:23 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110769 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	308 label Biography information for Mr Jim Cunningham

1104981

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Tomography: Oxford
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, if he will place in the Library any impact assessment conducted on the proposed privatisation of the PET-CT scan service in Oxford.
	tabling member constituency	Oxford East
	tabling member printed	Anneliese Dodds
	uin	236567
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>In line with NHS England’s usual processes, an Equalities Impact Assessment will be undertaken where it is certain that there could be substantive changes to service provision. In relation to the outcome of the Lot 4 procurement, this would be triggered in the event there was no alternative proposal but to move the service from the Churchill Hospital site to another location in Oxford.</p><p> </p><p>NHS England has not yet conducted the Equalities Impact Assessment because all parties, including Oxford University Hospitals NHS Foundation Trust, are committed to ensuring that PET-CT services are retained on the Churchill site, as part of a wider network of provision and partnership arrangement between both the Trust and InHealth. NHS England is due to present a report to Oxfordshire’s joint Health Overview and Scrutiny Committee on 4 April 2019, setting out the proposals and next steps.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:45:05 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110763 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4657 label Biography information for Anneliese Dodds

1104997

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what support he plans to provide for myalgic encephalomyelitis services in the North East.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	236488
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>Services for people with myalgic encephalomyelitis are commissioned by local clinical commissioning groups. It is the responsibility of the local National Health Service commissioners to ensure NHS services are commissioned to meet local need and to address any shortfalls in provision, taking into account best practice guidance, such as that produced by the National Institute for Health and Care Excellence.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:42:50 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110764 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4127 label Biography information for Julie Elliott

1104998

	registered interest
	date	25/03/2019
	answering body	Department of Health and Social Care
	answering dept id	17
	answering dept short name	Health and Social Care
	answering dept sort name	Health and Social Care
	hansard heading	Chronic Fatigue Syndrome: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health and Social Care, what plans he has for the future development of services for people with myalgic encephalomyelitis in the North East.
	tabling member constituency	Sunderland Central
	tabling member printed	Julie Elliott
	uin	236489
	answer	answer is ministerial correction date of answer 29/03/2019 answer text <p>Services for people with myalgic encephalomyelitis are commissioned by local clinical commissioning groups. It is the responsibility of the local National Health Service commissioners to ensure NHS services are commissioned to meet local need and to address any shortfalls in provision, taking into account best practice guidance, such as that produced by the National Institute for Health and Care Excellence.</p> answering member constituency Gosport answering member printed Caroline Dinenage question first answered 29/03/2019 14:43:31 answering member 4008 label Biography information for Dame Caroline Dinenage previous answer version 110777 answering member constituency Gosport answering member printed Caroline Dinenage answering member 4008 label Biography information for Dame Caroline Dinenage
	tabling member	4127 label Biography information for Julie Elliott